Phenytoin is contraindicated in absence seizures?
Yes, phenytoin is contraindicated in absence seizures. Here's a quick summary before I look up the details:
- Phenytoin (a sodium channel blocker) can worsen absence seizures and may increase their frequency
- Absence seizures are mediated by thalamo-cortical T-type calcium channel activity, and phenytoin does not block T-type Ca²⁺ channels
- First-line drugs for absence seizures are ethosuximide (T-type Ca²⁺ channel blocker) and valproate
- Phenytoin is also contraindicated in other generalized seizures like myoclonic and atonic seizures
Searching sources...
Reading File
Finding Sources
Searching PubMed
phenytoin absence seizure worsening
Finding Sources
The textbooks confirm this clearly. Here is the full answer:
Phenytoin and Absence Seizures
Yes - phenytoin is contraindicated in absence seizures (petit mal epilepsy). Multiple authoritative sources confirm this:
- Goodman & Gilman states: "Phenytoin is effective against focal and generalized tonic-clonic seizures, but not generalized absence seizures."
- Katzung explicitly warns: "Phenytoin may worsen other seizure types in idiopathic generalized epilepsies, including absence epilepsy and juvenile myoclonic epilepsy, and in Dravet syndrome."
- Henry's Clinical Diagnosis confirms: "It is ineffective in treating myoclonus, absence (petit mal), and atonic seizures."
Why Does Phenytoin Fail in Absence Seizures?
Phenytoin's primary mechanism is blockade of voltage-gated sodium channels (Na⁺ channels) - it prolongs channel inactivation and prevents high-frequency neuronal firing. This works well for focal and tonic-clonic seizures.
Absence seizures, however, are generated by T-type calcium (Ca²⁺) channel activity in the thalamo-cortical circuits. Phenytoin has no effect on T-type Ca²⁺ channels, and can actually paradoxically increase absence seizure frequency.
Phenytoin is Also Ineffective/Contraindicated In:
| Seizure Type | Why |
|---|---|
| Absence (petit mal) | T-type Ca²⁺ channel mechanism; phenytoin worsens it |
| Myoclonic seizures | May worsen (seen in JME) |
| Atonic seizures | Ineffective |
| Dravet syndrome | Can worsen |
First-Line Treatment for Absence Seizures:
- Ethosuximide - selective T-type Ca²⁺ channel blocker; drug of choice for pure absence seizures
- Valproate (valproic acid) - broad-spectrum; preferred when absence co-exists with tonic-clonic seizures
- Lamotrigine - second-line option
Key exam point: Phenytoin is effective for focal seizures and tonic-clonic seizures but is contraindicated (and potentially worsening) in absence, myoclonic, and atonic seizures. Always choose ethosuximide or valproate for absence seizures.
(Sources: Goodman & Gilman's Pharmacological Basis of Therapeutics; Katzung's Basic and Clinical Pharmacology, 16th Ed.; Henry's Clinical Diagnosis and Management)
This is a shared conversation. Sign in to Orris to start your own chat.